Literature DB >> 3467311

Hemoglobin S Antilles: a variant with lower solubility than hemoglobin S and producing sickle cell disease in heterozygotes.

N Monplaisir, G Merault, C Poyart, M D Rhoda, C Craescu, M Vidaud, F Galacteros, Y Blouquit, J Rosa.   

Abstract

We have found a sickling variant, Hb S Antilles, alpha 2 beta 2(6 Glu----Val, 23 Val----Ile), that has the same electrophoretic mobility as Hb S but a distinct isoelectric focus and produces sickling in the carriers of the Hb A/S Antilles trait. The carriers' erythrocytes tend to sickle at O2 partial pressures similar to those that induce sickling in Hb S/C disease. Pure deoxy-Hb S Antilles is 50% as soluble as deoxy-Hb S (saturating concentration = 11 g X dl-1 compared to 18.4 for Hb S). Dilute solutions of pure Hb S Antilles have a lower oxygen affinity than those of Hb A or Hb S (partial pressure for 50% binding is 9 mm Hg compared to 5.5 mm Hg for Hb A or S at pH 7.00). A/S Antilles erythrocytes have a much lower oxygen affinity than A/S cells; this is further decreased in dense cells fractionated on a Percoll density gradient. Their oxygen equilibrium curves had anomalous shapes like those of S/S cells. Fiber formation in the erythrocytes of Hb S Antilles carriers is clearly due to its low solubility and oxygen affinity, showing that heterozygosity for this hemoglobin presents another sickle cell syndrome and suggesting that Hb S heterozygotes who exhibit symptoms of sickle cell disease should be carefully screened for double mutations.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3467311      PMCID: PMC387138          DOI: 10.1073/pnas.83.24.9363

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  22 in total

1.  DETERMINATION OF DENSITY DISTRIBUTION OF RED CELL POPULATION.

Authors:  D DANON; V MARIKOVSKY
Journal:  J Lab Clin Med       Date:  1964-10

2.  Hemoglobin C Ziguinchor alphaA2 beta62 (A3) Glu leads to Val beta58 (E2) Pro leads to Arg: the second sickling variant with amino acid substitutions in 2 residues of the beta polypeptide chain.

Authors:  M Goossens; M C Garel; J Auvinet; O Basset; P Ferreira Gomes; J Rosa; N Arous
Journal:  FEBS Lett       Date:  1975-10-15       Impact factor: 4.124

3.  Haemoglobin Strasbourg alpha2beta2 23 (B5) Val replaced by Asp: revised structure anf functional properties.

Authors:  M Cohen-Solal; M L North; J Thillet; K Albrecht-Ellmer; M C Garel; Y Blouquit; J Rosa; C Valentin
Journal:  FEBS Lett       Date:  1978-06-15       Impact factor: 4.124

4.  Thermodynamics of gelation of sickle cell deoxyhemoglobin.

Authors:  P D Ross; J Hofrichter; W A Eaton
Journal:  J Mol Biol       Date:  1977-09-15       Impact factor: 5.469

5.  Cleavage at glutamic acid with staphylococcal protease.

Authors:  G R Drapeau
Journal:  Methods Enzymol       Date:  1977       Impact factor: 1.600

6.  alpha Chain mutations with opposite effects on the gelation of hemoglobin S.

Authors:  R E Benesch; S Kwong; R Edalji; R Benesch
Journal:  J Biol Chem       Date:  1979-09-10       Impact factor: 5.157

7.  Isoelectric focusing of human hemoglobin: its application to screening, to the characterization of 70 variants, and to the study of modified fractions of normal hemoglobins.

Authors:  P Basset; Y Beuzard; M C Garel; J Rosa
Journal:  Blood       Date:  1978-05       Impact factor: 22.113

8.  Structure and properties of hemoglobin C-Harlem, a human hemoglobin variant with amino acid substitutions in 2 residues of the beta-polypeptide chain.

Authors:  R M Bookchin; R L Nagel; H M Ranney
Journal:  J Biol Chem       Date:  1967-01-25       Impact factor: 5.157

9.  Hemoglobin S Travis: a sickling hemoglobin with two amino acid substitutions [beta6(A3)glutamic acid leads to valine and beta142 (h20) alanine leads to valine).

Authors:  W F Moo-Penn; R M Schmidt; D L Jue; K C Bechtel; J M Wright; M K Horne; G L Haycraft; E F Roth; R L Nagel
Journal:  Eur J Biochem       Date:  1977-08-01
View more
  19 in total

1.  Permanence or change? The meaning of genetic variation.

Authors:  F M Salzano
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

2.  Steric and hydrophobic determinants of the solubilities of recombinant sickle cell hemoglobins.

Authors:  M T Bihoreau; V Baudin; M Marden; N Lacaze; B Bohn; J Kister; O Schaad; A Dumoulin; S J Edelstein; C Poyart
Journal:  Protein Sci       Date:  1992-01       Impact factor: 6.725

3.  Insights into the pathogenesis of dominant retinitis pigmentosa associated with a D477G mutation in RPE65.

Authors:  Elliot H Choi; Susie Suh; Christopher L Sander; Christian J Ortiz Hernandez; Elizabeth R Bulman; Nimesh Khadka; Zhiqian Dong; Wuxian Shi; Krzysztof Palczewski; Philip D Kiser
Journal:  Hum Mol Genet       Date:  2018-07-01       Impact factor: 6.150

4.  Introduction and expression of the human Bs-globin gene in transgenic mice.

Authors:  E M Rubin; R H Lu; S Cooper; N Mohandas; Y W Kan
Journal:  Am J Hum Genet       Date:  1988-04       Impact factor: 11.025

5.  Four is not more than two.

Authors:  D W Russell; P C White
Journal:  Am J Hum Genet       Date:  1995-11       Impact factor: 11.025

Review 6.  The molecular basis of genetic dominance.

Authors:  A O Wilkie
Journal:  J Med Genet       Date:  1994-02       Impact factor: 6.318

7.  Mapping polymerization and allostery of hemoglobin S using point mutations.

Authors:  Patrick Weinkam; Andrej Sali
Journal:  J Phys Chem B       Date:  2013-09-09       Impact factor: 2.991

8.  A review of clinical profile in sickle cell traits.

Authors:  Nitin John
Journal:  Oman Med J       Date:  2010-01

9.  A neutral variant involved in a complex CFTR allele contributes to a severe cystic fibrosis phenotype.

Authors:  Jérôme Clain; Jacqueline Lehmann-Che; Emmanuelle Girodon; Joanna Lipecka; Aleksander Edelman; Michel Goossens; Pascale Fanen
Journal:  Hum Genet       Date:  2005-03-03       Impact factor: 4.132

10.  Transgenic knockout mice exclusively expressing human hemoglobin S after transfer of a 240-kb betas-globin yeast artificial chromosome: A mouse model of sickle cell anemia.

Authors:  J C Chang; R Lu; C Lin; S M Xu; Y W Kan; S Porcu; E Carlson; M Kitamura; S Yang; L Flebbe-Rehwaldt; K M Gaensler
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-08       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.